Investors & Media

Press Releases

View all press releases »

Ionis to hold second quarter 2022 financial results webcast

July 27, 2022 at 7:05 AM EDT

Webcast scheduled for Tuesday, August 9 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., July 27, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Tuesday, August 9th at 11:30 a.m. Eastern Time to discuss its second quarter financial results and report on pipeline and business progress.

The webcast may be accessed at A  replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company.

To learn more about Ionis visit and follow us on Twitter @ionispharma.

Cision View original content to download multimedia:

SOURCE Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals Investor Contact: 760-603-2331; Ionis Pharmaceuticals Media Contact: 760-603-4679